Continuous antihypertensive therapy throughout the initial 24 hours of intracerebral hemorrhage: The stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study

Stroke

Volumn 45, Issue 3, 2014, Pages 868-870

  Kobayashi, Junpei ^a   Koga, Masatoshi ^a   Tanaka, Eijirou ^a   Okada, Yasushi ^b   Kimura, Kazumi ^c   Yamagami, Hiroshi ^d   Okuda, Satoshi ^e   Hasegawa, Yasuhiro ^f   Shiokawa, Yoshiaki ^g   Furui, Eisuke ^h   Nakagawara, Jyoji ⁱ   Kario, Kazuomi ^j   Okata, Takuya ^a   Arihiro, Shoji ^a   Sato, Shoichiro ^a   Nagatsuka, Kazuyuki ^a   Minematsu, Kazuo ^a   Toyoda, Kazunori ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^c KAWASAKI MEDICAL SCHOOL   (Japan)

^d Stroke Center   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^f ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g KYORIN UNIVERSITY   (Japan)

^h KOHNAN HOSPITAL   (Japan)

ⁱ Nakamura Memorial Hospital   (Japan)

^j JICHI MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

Acute; Antihypertensives; Cerebral hemorrhage; Patient outcome assessment; Stroke

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BRAIN HEMATOMA; BRAIN HEMORRHAGE; FEMALE; GLASGOW COMA SCALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT OUTCOME; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; DISEASE COURSE; DRUG EFFECT; MIDDLE AGED; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PATHOLOGY; STATISTICAL MODEL; STROKE, ACUTE;

ANTIHYPERTENSIVES; CEREBRAL HEMORRHAGE; PATIENT OUTCOME ASSESSMENT; STROKE, ACUTE;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CEREBRAL HEMORRHAGE; CONFIDENCE INTERVALS; DISEASE PROGRESSION; FEMALE; GLASGOW COMA SCALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 84899490485     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.004319     Document Type: Article

References (11)

1. Davis SM, Broderick J, Hennerici M, Bran NC, Diringer MN, Mayer SA, et al; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66:1175-1181.
2. Mayer S A, Sacco RL, Shi T, Mohr JP. Neurologic deterioration in nonco- matose patients with supratentorial intracerebral hemorrhage. Neurology. 1994;44:1379-1384.
3. Fogelholm R, Avikainen S, Murros K. Prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage. Stroke. 1997;28:1396-1400.
4. Itabashi R, Toyoda K, Yasaka M, Kuwashiro T, Nakagaki H, Miyashita F, et al. The impact of hyperacute blood pressure lowering on the early clinical outcome following intracerebral hemorrhage. J Hypertens. 2008;26:2016-2021.
5. Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, et al; INTERACT2 Investigators. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368:2355-2365.
6. Qureshi Al, Palesch YY. Antihypertensive treatment of acute cerebral hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care. 2011;15:559-576.
7. Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke. 1996;27:1783-1787.
8. Koga M, Toyoda K, Yamagami H, Okuda S, Okada Y, Kimura K, et al. Systolic blood pressure lowering to 160 mmHg or less using nicardipine in acute intracerebral hemorrhage: A prospective, multicenter, observational study (the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study). J Hypertens. 2012;30:2357-2364.
9. Sakamoto Y, Koga M, Yamagami H, Okuda S, Okada Y, Kimura K, et al; SAMURAI Study Investigators. Systolic blood pressure after intravenous antihypertensive treatment and clinical outcomes in hyperacute intracerebral hemorrhage: The stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study. Stroke. 2013;44:1846-1851.
10. Herbstein DJ, Schaumberg HH. Hypertensive intracerebral hematoma. An investigation of the initial hemorrhage and rebleeding using chromium Cr 51-labeled erythrocytes. Arch Neurol. 1974;30:412-414.
11. Vemmos KN, Tsivgoulis G, Spengos K, Zakopoulos N, Synetos A, Kotsis V, et al. Association between 24-h blood pressure monitoring variables and brain oedema in patients with hyperacute stroke. J Hypertens. 2003;21:2167-2173.